Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A2 receptor antibody-positive idiopathic membranous nephropathy: a case report

Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A2 receptor antibody-positive idiopathic membranous nephropathy: a case report

Abstract Background Idiopathic membranous nephropathy (MN) is one of the major glomerulonephritis that cause nephrotic syndrome. The phospholipase A2 receptor (PLA2R) has recently been identified as an endogenous antigen of idiopathic MN. Thrombotic thrombocytopenic purpura (TTP) is a disorder chara...

Full description

Bibliographic Details
Main Authors: Rei Iio, Shin’ichi Akiyama, Kensuke Mitsumoto, Yukimasa Iwata, Hiroki Okushima, Karin Shimada, Naomi Ota, Kodo Tomida, Hiroaki Fushimi, Tatsuya Shoji, Masanori Matsumoto, Terumasa Hayashi
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Nephrology
Subjects:
Anti-PLA2R antibody
Idiopathic membranous nephropathy
ADAMTS13 inhibitor
Acquired thrombotic thrombocytopenic purpura
Online Access:http://link.springer.com/article/10.1186/s12882-020-02086-z

Internet

http://link.springer.com/article/10.1186/s12882-020-02086-z

Similar Items